SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ribi Immunochem (ribi)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sherryl A Howell who wrote (24)2/14/1997 3:32:00 AM
From: tim quane   of 92
 
I beleive there was 11 large blocks today. I was unable to find out any news but the large volume (for ribi)and up 3/8 and finally breaking 5.5 is encouraging. I have 3 guesses. 1. they are about to submit melacine for an n.d.a. to the canadiens branch of medicine,like are f.d.a. 2. they have found a marketer for melacine in the u.s. or europe. and 3. Smithkline is accumalating more shares per there last agreement. one other note of interest is first call (an earnings forcast company) has ribi earning .32 cents for 1998. the first time i ever saw anyone showing ribi with a profit. there annual report due out next month should be interesting because they always say they expect revenue to be limited for at least the next few years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext